Literature DB >> 19679055

Vitamin D receptor variants and the malignant melanoma risk: a population-based study.

P Gapska1, R J Scott, P Serrano-Fernandez, A Mirecka, I Rassoud, B Górski, C Cybulski, T Huzarski, T Byrski, L Nagay, R Maleszka, M Sulikowski, J Lubinski, T Debniak.   

Abstract

BACKGROUND: There is continuing interest in identifying low-penetrance genes which are associated with an increased susceptibility to common types of cancer, including malignant melanoma.
METHODS: We sought to examine the association between four VDR common variants (rs1544410, rs731236, rs10735810, rs4516035) and the risk of melanoma in the Polish population. We also determined the prevalence of compound carriers of VDR and known MM genetic risk factors MC1R and CDKN2A (A148T) variants. We examined 763 unselected melanoma cases, 763 healthy adults matched for sex and age with the melanoma cases and 777 newborns.
RESULTS: None of the VDR variants alone or as compound carriers of two or more of the VDR genotypes were associated with MM risk. There were no major differences between the prevalences of the examined variants among patients with MM on UV-exposed and UV-non exposed skin areas, as well as among early-onset and late-onset cases. We found no association between VDR and MC1R or between VDR and CDKN2A common variants. A statistically significant over-representation of one VDR haplotype: rs731236_A+rs1544410_T (OR=3.2, p=0.02) was detected. Linkage disequilibrium of rs1544410 and rs731236 was confirmed.
CONCLUSION: To answer the question, whether VDR can be regarded as melanoma susceptibility gene, additional, large multi-center association studies have to be performed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679055     DOI: 10.1016/j.canep.2009.06.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  17 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 2.  Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Wojciech Jóźwicki; Anton M Jetten; Rebecca S Mason; Robert C Tuckey; Craig A Elmets
Journal:  Lab Invest       Date:  2017-02-20       Impact factor: 5.662

3.  Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

Authors:  Rochelle Mandelcorn-Monson; Loraine Marrett; Anne Kricker; Bruce K Armstrong; Irene Orlow; Chris Goumas; Susan Paine; Stefano Rosso; Nancy Thomas; Robert C Millikan; Jason D Pole; Javier Cotignola; Cheryl Rosen; Peter A Kanetsky; Julia Lee-Taylor; Colin B Begg; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

4.  Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.

Authors:  Nicole Denzer; Thomas Vogt; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

5.  Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative study.

Authors:  Haiyong Gu; Xu Wang; Liang Zheng; Weifeng Tang; Changqing Dong; Liming Wang; Yijun Shi; Aizhong Shao; Guowen Ding; Chao Liu; Ruiping Liu; Suocheng Chen; Jun Yin
Journal:  Med Oncol       Date:  2014-01-01       Impact factor: 3.064

6.  Vitamin D receptor polymorphisms in patients with cutaneous melanoma.

Authors:  Irene Orlow; Pampa Roy; Anne S Reiner; Sarah Yoo; Himali Patel; Susan Paine; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Nancy E Thomas; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Peter A Kanetsky; Klaus Busam; Lynn From; Colin B Begg; Marianne Berwick
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

7.  Melanoma incidence rates among whites in the U.S. Military.

Authors:  Jing Zhou; Lindsey Enewold; Shelia H Zahm; Susan S Devesa; William F Anderson; John F Potter; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-08       Impact factor: 4.254

8.  Vitamin D and melanoma incidence and mortality.

Authors:  Marianne Berwick; Eszter O Erdei
Journal:  Pigment Cell Melanoma Res       Date:  2012-10-24       Impact factor: 4.693

9.  rs12512631 on the group specific complement (vitamin D-binding protein GC) implicated in melanoma susceptibility.

Authors:  Maria Peña-Chilet; Maider Ibarrola-Villava; Manuel Martin-González; Marta Feito; Cristina Gomez-Fernandez; Dolores Planelles; Gregorio Carretero; Ana Lluch; Eduardo Nagore; Gloria Ribas
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

10.  Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies.

Authors:  Sara Raimondi; Sara Gandini; Maria Concetta Fargnoli; Vincenzo Bagnardi; Patrick Maisonneuve; Claudia Specchia; Rajiv Kumar; Eduardo Nagore; Jiali Han; Johan Hansson; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Terry Dwyer; Leigh Blizzard; Ricardo Fernandez-de-Misa; Wojciech Branicki; Tadeusz Debniak; Niels Morling; Maria Teresa Landi; Giuseppe Palmieri; Gloria Ribas; Alexander Stratigos; Lynn Cornelius; Tomonori Motokawa; Sumiko Anno; Per Helsing; Terence H Wong; Philippe Autier; José C García-Borrón; Julian Little; Julia Newton-Bishop; Francesco Sera; Fan Liu; Manfred Kayser; Tamar Nijsten
Journal:  BMC Med Res Methodol       Date:  2012-08-03       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.